-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
enGene Holdings Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q4 2022 to Q3 2024.
- enGene Holdings Inc. Earnings Per Share, Diluted for the quarter ending October 31, 2024 was 0.3 USD/shares, a 99.8% decline year-over-year.
- enGene Holdings Inc. Earnings Per Share, Diluted for the twelve months ending October 31, 2024 was 1.46 USD/shares, a 99% decline year-over-year.
- enGene Holdings Inc. annual Earnings Per Share, Diluted for 2024 was 1.46 USD/shares, a 99% decline from 2023.
- enGene Holdings Inc. annual Earnings Per Share, Diluted for 2023 was 151 USD/shares, a 241% increase from 2022.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)